US2010070020A1PendingUtilityA1

Implantable Medical Device

Assignee: NANOVASC INCPriority: Jun 11, 2008Filed: Dec 3, 2009Published: Mar 18, 2010
Est. expiryJun 11, 2028(~1.9 yrs left)· nominal 20-yr term from priority
A61L 2300/00A61L 31/16A61L 31/06A61L 31/10A61F 2/07A61L 31/129A61F 2/06A61F 2/82A61L 31/148A61L 2400/12
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides an implantable medical device comprising a fibrous polymer body comprising a plurality of electrospun poly(urethane) fibers, a support filament wrapped around the body, an outer layer around the filament for adhering the filament to the body, the outer layer comprising a plurality of electrospun poly(urethane) fibers, and a polymer primer coating at least the fibers of the body. The polymer primer comprises poly(lactide) and is attached to a heparin residue through a linker

Claims

exact text as granted — not AI-modified
1 . An implantable medical device comprising:
 a fibrous polymer body comprising electrospun poly(urethane) fiber;   a support filament wrapped around the body;   an outer layer around the filament for adhering the filament to the body, the outer layer comprising electrospun poly(urethane) fiber; and   a covering composition covering the fiber of the body, the polymer primer comprising poly(lactide) and having the formula:   
     
       
         
         
             
             
         
       
       wherein A is a heparin residue, n is an integer between about 1000 and about 10000, and m is an integer between about 50 and about 100. 
     
   
   
       2 . The device according to  claim 1 , wherein the body comprises a plurality of thermoplastic poly(urethane) fibers. 
   
   
       3 . The device according to  claim 1 , wherein the filament comprises thermoplastic polyether urethane. 
   
   
       4 . The device according to  claim 1 , wherein the filament is configured to provide a degree of anti-kinking resistance to the device. 
   
   
       5 . The device according to  claim 3 , wherein the filament is configured to prevent kinking of the device when bending at a radius greater than about 1 mm. 
   
   
       6 . The device according to  claim 5 , wherein the filament is spirally wound around the body and has a pitch of between about 1 mm and about 6 mm. 
   
   
       7 . The device according to  claim 6 , wherein the filament is spirally wound around the body and has a pitch of about 4 mm. 
   
   
       8 . The device according to  claim 1 , wherein the outer layer comprises a plurality of thermoplastic poly(urethane) fibers. 
   
   
       9 . The device according to  claim 1 , the body and outer layer each comprising a plurality of electrospun fibers, wherein essentially all of the fibers of the body and outer layer are covered with the covering composition. 
   
   
       10 . The device according to  claim 1 , wherein the body is monolithically formed and the covering composition is integrated into the body by dip coating. 
   
   
       11 . The device according to  claim 1 , the body comprising a plurality of electrospun fibers, wherein the covering composition layer fills interstices between the plurality of fibers. 
   
   
       12 . The device according to  claim 1 , wherein the covering composition is attached to the body by adsorption. 
   
   
       13 . The device according to  claim 1 , wherein A is heparin sodium. 
   
   
       14 . The device according to  claim 1 , wherein the device is a tubular vascular graft. 
   
   
       15 . The device according to  claim 1  produced by the process comprising:
 electrospinning the fibrous polymer body, the body comprising a plurality of electrospun fibers;   wrapping the support filament around the electrospun body;   providing the electrospun outer layer around the filament to adhere the filament to the body thereby forming an uncoated device;   applying a polymer primer comprising poly(lactide) in a solution to the uncoated device under sufficient conditions to cause attachment of the polymer primer to at least one of the plurality of fibers of the body;   after the applying, immobilizing a linker molecule to the applied polymer primer, the linker molecule forming a covalent bond with the primer; and   after the immobilizing, covalently attaching the heparin residue to the immobilized linker molecule thereby forming the covering composition on the at least one fiber.   
   
   
       16 . The method according to  claim 15 , wherein the polymer primer solution has an inherent viscosity midpoint of about 2.0 dl/g at room temperature. 
   
   
       17 . The method according to  claim 16 , wherein the applying is performed under sufficient conditions such that essentially all of the plurality of fibers of the body are covered with the polymer primer. 
   
   
       18 . The method according to  claim 16 , wherein the applying, immobilizing and attaching are accomplished by successive dip coating.

Join the waitlist — get patent alerts

Track US2010070020A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.